Answers are grounded in this paper and cite their sources.
The WHO and many other diabetes organizations recommend performing OGTT at fasting plasma glucose ≥ 6.1 ÷ 6.9 mmol/L mmol/L, but ADA indicates a lower cut-off for this parameter - ≥ 5.6 ÷ 6.0 mmol/L mmol/L. Aim: We decided to evaluate the role of baseline glucose tolerance for the development of Diabetes or Prediabetes over time by a prospective study of the changes in glucose tolerance 5 years after the last nationwide cross-sectional study in Bulgaria. Material: The study included 204 subjects from a total of 2033 tested 5 years ago. These 204 individuals were selected among those with a fasting plasma glucose (FPG) 6.1 – 6.9 mmol/L (Group 1) and FPG ≥ 5.6 ÷ 6.0 mmol/L (Group 2) found during the screening in 2012. As a part of the screening in 2017, a standard OGTT was performed (WHO’1999) and HbA1c was determined. Methods: Plasma glucose was measured in all the studies by an automated glucose-oxidase analyzer (Glucose Analyzer II, Beckman Coulter, Inc). HbA1c was determined by immunoturbidimetric method after hemolysis of a whole blood sample. Results: Half of the subjects with FPG 6.1 - 6.9 mmol/L in 2012 had Diabetes during the follow up, 31% remained in the Prediabetes group and 19% had Normal glucose tolerance (NGT) in 2017. Among the subjects with FPG ≥ 5.6 - 6.0 mmol/L in 2012, 24.7% had Diabetes in 2017, 34.6% - Prediabetes and 40.7% had NGT. The difference in the Diabetes prevalence between the two groups was significant – 50% vs. 24.7% (T=2.443, P < 0.02). In 5 years’time, 29.9% of the Individuals who had FPG ≥ 5.6 - 6.9 mmol/L in 2012, became Diabetics, 33.6% became Prediabetics and only 36.3% had NGT. In 57% (35/61) of the diabetics the disease was newly diagnosed and in about 2/3 of the cases it was decompensated (HbA1c ≥ 7%). During the 5-year period, Diabetes was diagnosed in 26 (42.6%) persons and 34.6% of them were in metabolic decompensation under treatment. Conclusion: The most important conclusion from our screening from 2017 is that ¼ people with FPG ≥ 5.6 – 6.0 mmol/L after a few years became diabetics, so systematic efforts should be directed towards this border group.
No takes yet. Share an insight, caveat, or question.
Borissovа et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: